Compare HLF & INNV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HLF | INNV |
|---|---|---|
| Founded | 1980 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Pharmaceuticals | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.5B |
| IPO Year | 2004 | 2021 |
| Metric | HLF | INNV |
|---|---|---|
| Price | $13.18 | $9.02 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 3 |
| Target Price | ★ $17.00 | $12.00 |
| AVG Volume (30 Days) | ★ 1.4M | 418.6K |
| Earning Date | 11-02-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 90.91 |
| EPS | ★ 0.33 | N/A |
| Revenue | ★ $5,037,500,000.00 | $989,707,000.00 |
| Revenue This Year | $4.39 | $8.51 |
| Revenue Next Year | $2.51 | $7.99 |
| P/E Ratio | $39.56 | ★ N/A |
| Revenue Growth | 0.89 | ★ 15.93 |
| 52 Week Low | $7.94 | $3.94 |
| 52 Week High | $20.40 | $12.64 |
| Indicator | HLF | INNV |
|---|---|---|
| Relative Strength Index (RSI) | 50.49 | 41.26 |
| Support Level | $11.40 | $8.79 |
| Resistance Level | $14.89 | $9.23 |
| Average True Range (ATR) | 0.52 | 0.36 |
| MACD | -0.13 | 0.05 |
| Stochastic Oscillator | 19.71 | 21.88 |
Herbalife Ltd is a health and wellness company. It provides health and wellness products in 95 markets through a direct-selling business model. Its product categories include Weight Management, Targeted Nutrition, Energy, Sports and Fitness, Outer Nutrition, and Literature, Promotional, and Other. Weight Management generates the majority of revenue, with products such as meal replacements, protein shakes, drink mixes, weight loss enhancers, and healthy snacks. Products are manufactured at facilities in Changsha and Suzhou, China; Lake Forest, California; and Winston-Salem, North Carolina, as well as by third-party providers. Revenues reflect sales to Members across North America, Latin America, EMEA, Asia Pacific, and China.
InnovAge Holding Corp is a healthcare delivery platform comprising multiple participants focused on providing all-inclusive, capitated care to high-cost seniors, many of whom are dual-eligible. Its programs are designed to address two of the pressing challenges facing the U.S. healthcare industry: rising costs and poor outcomes. The purpose of the participant-centered care delivery approach is to improve the quality of care participants receive, while keeping them in their homes for as long as possible and reducing the overutilization of high-cost care settings, such as hospitals and nursing homes. The company manages its business as one reportable segment, PACE.